journal article·2022-12Open access

Cubic upconversion nanoparticles used as the theranostic system for the treatment and diagnosis of angiogenesis-related diseases

W.H. Tse, S. Yang, J. Zhang

Abstract

Biocompatible nanostructures offer new pathways to overcome the obstacles in conventional anti-angiogenic therapy such as drug accumulation and therapeutic efficiency. However, current technology is limited by the bioavailability of therapeutics and the obstruction of imaging. Theranostic nanoparticles have been developed to bridge the gap between imaging and therapeutic delivery. In this paper, a theranostic system made of cubic lanthanide-based upconversion nanoparticles (UCNPs) has been developed. The average length of the cubic UCNPs is estimated at 53 ± 13 nm. The fluorescence intensity of the emission peaks of UNCPs in the visible range is dependent on the power of the excitation at a region of near-infrared (NIR), λex = 980 nm. In addition, cell imaging has demonstrated that the UNCPs conjugated with anti-VEGF antibodies show significant anti-angiogenic effects which are even stronger than their anti-VEGF counterpart. With the capabilities of both anti-angiogenic effects and cell imaging, the UCNPs-antiVEGF is a promising theranostic model at the nanoscale for the treatment and diagnosis of angiogenesis-related diseases .
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence Properties of Advanced Materials · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (59)

Show source-provided references
1. Apatinib for metastatic breast cancer in non-clinical trial setting: satisfying efficacy regardless of previous anti-angiogenic treatment10.1177/1010428317711033 ↗
2. Gold nanoparticles induced endothelial leakiness depends on particle size and endothelial cell origin10.1021/acsnano.7b01744 ↗
3. PLGA microparticles entrapping chitosan-based nanoparticles for the ocular delivery of ranibizumab10.1021/acs.molpharmaceut.6b00335 ↗
4. Aqueous vascular endothelial growth factor and clinical outcomes correlation after single intravitreal injection of bevacizumab in patients with neovascular age-related macular degeneration10.1186/s40942-017-0066-y ↗
5. Tumor angiogenesis revisited: regulators and clinical implications10.1002/med.21452 ↗
6. Rubanyi · 1999
7. Anti-VEGF therapies in the clinic10.1101/cshperspect.a006577 ↗
8. Mogamulizumab for the treatment of T-cell lymphoma10.1080/14712598.2017.1347634 ↗
9. Ferrara · 2006
10. Klagsbrun · 2012
11. Anti-VEGF treatment strategies for wet AMD
12. Age-related macular degeneration: a target for nanotechnology derived medicines10.2147/nano.2007.2.1.65 ↗
13. Implementation studies of ranibizumab for neovascular age-related macular degeneration10.1111/aos.12272 ↗
14. Profile of conbercept in the treatment of neovascular age-related macular degeneration
15. Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning10.2147/OPTH.S133332 ↗
16. Advances in pharmacotherapy for wet age-related macular degeneration10.1517/14656566.2015.1067679 ↗
17. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications10.1016/j.jconrel.2014.12.030 ↗
18. Moxifloxacin loaded gelatin nanoparticles for ocular delivery: formulation and in-vitro, in-vivo evaluation10.1016/j.jcis.2016.08.018 ↗
19. A review of drug release mechanisms from nanocarrier systems10.1016/j.msec.2017.03.130 ↗
20. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery10.1016/j.addr.2015.09.012 ↗
21. Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives10.1039/C1NR11277E ↗
22. Nanoengineering of therapeutics for retinal vascular disease10.1016/j.ejpb.2015.05.001 ↗
23. Nanoparticle-based theranostic agents10.1016/j.addr.2010.07.009 ↗
24. Smart multifunctional nanoparticles in nanomedicine10.1515/bnm-2015-0030 ↗
25. Nanoparticles-a review
26. Biodegradable polymeric nanoparticles based drug delivery systems10.1016/j.colsurfb.2009.09.001 ↗
27. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles10.1016/S0378-5173(02)00548-3 ↗
28. Protein-based nanoparticles: from preparation to encapsulation of active molecules10.1016/j.ijpharm.2017.01.067 ↗
29. Development of photostable fluorophores for molecular imaging10.1016/j.cbpa.2017.04.017 ↗
30. Standard fluorescent imaging of live cells is highly genotoxic10.1002/cyto.a.22291 ↗
31. Aime · 2008
32. Special properties of luminescent magnetic NaGdF4:Yb3+, Er3+ upconversion nanocubes with surface modifications10.1039/C7RA03380J ↗
33. Paramagnetic nanocrystals: remarkable lanthanide-doped nanoparticles with varied shape, size, and composition10.1021/jz301562m ↗
34. NaGdF4 nanoparticle-based molecular probes for magnetic resonance imaging of intraperitoneal tumor xenografts in vivo10.1021/nn304837c ↗
35. In vitro cell imaging using multifunctional small sized KGdF4:Yb3+,Er3+ upconverting nanoparticles synthesized by a one-pot solvothermal process10.1039/c3nr00081h ↗
36. Preparation of core-shell NaGdF4 nanoparticles doped with luminescent lanthanide ions to be used as upconversion-based probes10.1038/nprot.2014.111 ↗
37. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties10.1016/j.biomaterials.2010.01.040 ↗
38. NIR-driven smart theranostic nanomedicine for on-demand drug release and synergistic antitumour therapy
39. Near-infrared fluorophores for biomedical imaging10.1038/s41551-016-0010 ↗
40. Dual-color emissive upconversion nanocapsules for differential cancer bioimaging in vivo10.1021/acsnano.5b07075 ↗
41. Long blood residence and large tumor uptake of ruthenium sulfide nanoclusters for highly efficient cancer photothermal therapy
42. Synthesis and characterization of NaYF4:Yb, Er up-conversion phosphors/poly(vinyl alcohol) composite fluorescent films10.1166/mex.2018.1420 ↗
43. A cis-diol/pH dual-responsive upconversion nanoplatform: synthesis, characterization, and in vitro demonstration10.1166/jbn.2019.2700 ↗
44. Preparation and evaluation of upconversion nanoparticles based miRNA delivery carrier in colon cancer mice model10.1166/jbn.2019.2840 ↗
45. Synthesis and luminescence properties of water soluble α-NaGdF4/β-NaYF4:Yb,Er core–shell nanoparticles10.1186/s11671-017-2306-3 ↗
46. A core-shell-shell nanoplatform upconverting near-infrared light at 808 nm for luminescence imaging and photodynamic therapy of cancer10.1038/srep10785 ↗
47. Upconverting nanoparticles for pre-clinical diffuse optical imaging, microscopy and sensing: current trends and future challenges10.1002/lpor.201200052 ↗
48. Development of biocompatible NaGdF4: Er3+, Yb3+ upconversion nanoparticles used as contrast agents for bio-imaging10.1002/cjce.23510 ↗
49. Mesoporous NaYbF4@NaGdF4 core-shell up-conversion nanoparticles for targeted drug delivery and multimodal imaging10.1016/j.biomaterials.2014.05.051 ↗
50. In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents10.1016/j.mvr.2007.05.006 ↗
51. Four types of inorganic nanoparticles stimulate the inflammatory reaction in brain microglia and damage neurons in vitro10.1016/j.toxlet.2012.08.009 ↗
52. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: risk factors for early atherosclerosis10.1016/j.toxlet.2011.03.021 ↗
53. Metallic nanoparticles exhibit paradoxical effects on oxidative stress and pro-inflammatory response in endothelial cells in vitro10.1177/039463200702000404 ↗
54. The use of human umbilical vein endothelial cells (HUVECs) as an in vitro model to assess the toxicity of nanoparticles to endothelium: a review10.1002/jat.3470 ↗
55. Role of inflammatory mediators in angiogenesis10.2174/1568010053622830 ↗
56. Carbon black nanoparticles and vascular dysfunction in cultured endothelial cells and artery segments10.1016/j.toxlet.2012.07.022 ↗
57. Endothelial cell activation, oxidative stress and inflammation induced by a panel of metal-based nanomaterials10.3109/17435390.2014.980449 ↗
58. Monocyte adhesion induced by multi-walled carbon nanotubes and palmitic acid in endothelial cells and alveolar–endothelial co-cultures
59. Deposition of antibody modified upconversion nanoparticles on glass by a laser-assisted method to improve the performance of cell culture10.1186/s11671-019-2918-x ↗